https://immuthera.bio/immuthera-at-bio-international-convention-2025/2025-06-20T12:57:49+02:00https://immuthera.bio/world-class-experts-join-immutheras-scientific-advisory-board/2025-07-04T15:36:29+02:00https://immuthera.bio/poltreg-establishes-u-s-subsidiary-immuthera-to-advance-international-development-strategy/2025-07-10T09:17:04+02:00https://immuthera.bio/immuthera-and-parent-company-poltreg-secures-positive-fda-opinion-paving-the-way-for-a-registrational-pre-symptomatic-type-1-diabetes-trial/2025-08-01T14:46:38+02:00https://immuthera.bio/dr-adrian-bot-joins-immuthera-to-support-the-company-with-his-unique-experience-in-commercialization-of-groundbreaking-cell-therapies/2025-11-07T14:34:23+01:00https://immuthera.bio/immuthera-announces-global-exclusive-license-from-city-of-hope-for-first-in-class-cd6-ctla-4-car-treg-platform-for-autoimmune-and-inflammatory-diseases/2026-01-12T15:53:57+01:00https://immuthera.bio/immuthera-appoints-dr-antionette-moran-dr-jason-gaglia-and-dr-jeffrey-cohen-renowned-endocrinologists-diabetologists-and-neuroscientist-to-the-scientific-advisory-board-sab/2026-01-21T12:41:23+01:00https://immuthera.bio/dr-michael-rosenblum-leading-university-of-california-ucsf-immunologist-and-dermatologist-appointed-to-immuthera-scientific-advisory-board/2026-06-02T14:41:43+02:00https://immuthera.bio/prof-piotr-trzonkowski-co-authored-a-prestigious-publication-in-frontiers-in-science-with-a-nobel-prize-winner/2026-06-30T13:12:31+02:00